                         SEQUENCE LISTING

<110>  OSE IMMUNOTHERAPEUTICS
 
<120>  METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY

<130>  B2418EP

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is d-alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is a cyclohexylalanine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is d-alanine

<400>  1

Xaa Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala Xaa 
1               5                   10              


<210>  2
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  2

Arg Leu Leu Gln Glu Thr Glu Leu Val 
1               5                   


<210>  3
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  3

Tyr Leu Gln Leu Val Phe Gly Ile Glu Val 
1               5                   10  


<210>  4
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  4

Leu Leu Thr Phe Trp Asn Pro Pro Val 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  5

Ser Met Pro Pro Pro Gly Thr Arg Val 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  xaa is alpha-aminobutyric acid

<400>  6

Lys Leu Xaa Pro Val Gln Leu Trp Val 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  7

Lys Val Phe Gly Ser Leu Ala Phe Val 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  8

Tyr Leu Ser Gly Ala Asp Leu Asn Leu 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  9

Ile Met Ile Gly His Leu Val Gly Val 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  10

Lys Val Ala Glu Ile Val His Phe Leu 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  peptide

<400>  11

Phe Leu Asp Glu Phe Met Glu Gly Val 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  12

Val Val Met Ser Trp Ala Pro Pro Val 
1               5                   


<210>  13
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  13

Leu Leu Leu Asp Asp Leu Leu Val Ser Ile 
1               5                   10  


<210>  14
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  14

Ser Leu Ala Asp Glu Ala Glu Val Tyr Leu 
1               5                   10  


<210>  15
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  15

Val Leu His Asp Asp Leu Leu Glu Ala 
1               5                   


<210>  16
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  16

Gly Ile Val Glu Gly Leu Ile Thr Thr Val 
1               5                   10  


<210>  17
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  17

Ser Leu Phe Glu Gly Ile Asp Ile Tyr Thr 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  18

Phe Ile Ala Ser Asn Gly Val Lys Leu Val 
1               5                   10  


<210>  19
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  19

Ile Leu Asn Ala Met Ile Ala Lys Ile 
1               5                   


<210>  20
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  20

Gly Leu Phe Gly Asp Ile Tyr Leu Ala Ile 
1               5                   10  


<210>  21
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  21

Ile Leu Asp Lys Val Leu Val His Leu 
1               5                   


<210>  22
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  22

Ala Cys Asp Pro His Ser Gly His Phe Val 
1               5                   10  


